Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Intensification of Early-Phase Therapy to Diminish the Prognostic Effect of Myeloid Antigen Expression in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL-10 Trial

Yuki Arakawa, Takashi Ishihara, Takako Miyamura, Takao Deguchi, Masashi Sanada, Toshinori Hori, Tomomi Yamada, Yuki Aoki, Sae Ishimaru, Takayuki Takachi, Mio Yano, Shinya Sasaki, Akiko M Saito, Atsushi Manabe, Keizo Horibe, Toshihiko Imamura, Daisuke Tomizawa

Blood (2021) 138 (Supplement 1): 2384.

https://doi.org/10.1182/blood-2021-145955

Published: 2021

Journal Articles

Outcome of Hematopoietic Stem Cell Transplantation in the Patients with Pediatric Acute Lymphoblastic Leukemia Enrolled in the Japan Association of Childhood Leukemia Study (JACLS) ALL-02

Mio Yano, MD, Hisashi Ishida, MD PhD, Yoshiko Hashii, MD PhD, Asahito Hama, MD PhD, Yoshiyuki Kosaka, MD PhD, Tsukasa Hori, MD PhD, Junichi Hara, MD, PhD, Hiroshi Kawaguchi, MD PhD, Etsuro Ito, MD PhD, Akiko M Saito, MD PhD, Atsushi Sato, MD PhD, Hiroki Hori, MD PhD, Keizo Horibe, MD PhD, Toshihiko Imamura, MD PhD

Blood (2019) 134 (Supplement_1): 4605.

https://doi.org/10.1182/blood-2019-122224

Published: 2019

Journal Articles

Leukemic Cell Expressing a Novel Kinase Fusion Protein NCOR1-LYN Exhibits High Sensitivity to Dasatinib and Rapamycin

Toshihiro Tomii, MD, Toshihiko Imamura, MD PhD, Mio Yano, MD, Kenichi Sakamoto, MD PhD, Itaru Kato, Kuniaki Tanaka, MD, Takashi Mikami, MD, Makiko Morita, PhD, Souichi Adachi, MD PhD, Junko Takita, MD, PhD, Nobutaka Kiyokawa, MD PhD, Keizo Horibe, MD PhD, Hajime Hosoi, MD PhD

Blood (2018) 132 (Supplement 1): 1557.

https://doi.org/10.1182/blood-2018-99-111612

Published: 2018

Journal Articles

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Chihiro Tomoyasu, MD, Toshihiko Imamura, MD, Mio Yano, MD, Daisuke Asai, MD, Meixian Huang, MD, Hiroaki Goto, MD PhD, Akira Shimada, MD PhD, Takeshi Inukai, MD PhD, Kanji Sugita, MD PhD, Hajime Hosoi, MD

Blood (2015) 126 (23): 1424.

https://doi.org/10.1182/blood.V126.23.1424.1424

Published: 2015

Journal Articles

Clinical Significance of LNK (SH2B3) Expression in Pediatric B Cell Precursor Acute Lymphoblastic Leukemia

Mio Yano, MD, Toshihiko Imamura, MD, Kenichi Sakamoto, MD, Daisuke Asai, MD, Gen Kano, MD, Hajime Hosoi, MD, Takao Deguchi, MD, Yoshiko Hashii, MD, Mikiya Endo, MD, Atsushi Sato, MD, Hirohide Kawasaki, MD, Yoshiyuki Kosaka, MD, Koji Kato, MDPhD, Hiroki Hori, MD, Keiko Yumura, MD, Junichi Hara, MD, Megumi Oda, MD, Stephen T. Oh, MD PhD, Keizo Horibe, MD

Blood (2014) 124 (21): 3772.

https://doi.org/10.1182/blood.V124.21.3772.3772

Published: 2014

Journal Articles

MLL-AF9 Positive Acute Myeloid Leukemia Cells Are Sensitive To All-Trans Retinoic Acid

Kenichi Sakamoto, MD, Toshihiko Imamura, MD, Mio Yano, MD, Hideki Yoshida, MD, Atsushi Fujiki, MD, Yoshifumi Hirashima, MD, Hajime Hosoi, MD

Blood (2013) 122 (21): 3827.

https://doi.org/10.1182/blood.V122.21.3827.3827

Published: 2013

Journal Articles

Prognostic Significance Of CRLF2 Over-Expression In Pediatric Acute Lymphoblastic Leukemia

Mio Yano, MD, Toshihiko Imamura, MD, Daisuke Asai, MD, Akiko Moriya Saito, MD, PhD, So-ichi Suenobu, MD, PhD, Daiichiro Hasegawa, MD, PhD, Takao Deguchi, MD, Yoshiko Hashii, MD, PhD, Hirohide Kawasaki, MD, Hiroki Hori, MD, Yoshiyuki Kosaka, MD, PhD, Koji Kato, MD, PhD, Keizo Horibe, MD, PhD, Keiko Yagi, MD, Junichi Hara, MD, PhD, Kenji Matsumoto, Nobutaka Kiyokawa, MD, PhD, Megumi Oda, MD, Atsushi Sato, MD

Blood (2013) 122 (21): 1368.

https://doi.org/10.1182/blood.V122.21.1368.1368

Published: 2013

Journal Articles

LSD1 Inhibitor Activates Retinoic Acid Pathway in MLL Fusion Positive Acute Myeloid Leukemia

Mio Yano, MD, Toshihiko Imamura, MD, Kenichi Sakamoto, MD, Hideki Yoshida, MD, Atsushi Fujiki, MD, Yoshifumi Hirashima, MD, Hiroyuki Ishida, MD, Hajime Hosoi, MD

Blood (2012) 120 (21): 1345.

https://doi.org/10.1182/blood.V120.21.1345.1345

Published: 2012

NARROW

Intensification of Early-Phase Therapy to Diminish the Prognostic Effect of Myeloid Antigen Expression in Infants with KMT2A -Rearranged Acute Lymphoblastic Leukemia: A Report from the JPLSG MLL-10 Trial

Outcome of Hematopoietic Stem Cell Transplantation in the Patients with Pediatric Acute Lymphoblastic Leukemia Enrolled in the Japan Association of Childhood Leukemia Study (JACLS) ALL-02

Leukemic Cell Expressing a Novel Kinase Fusion Protein NCOR1-LYN Exhibits High Sensitivity to Dasatinib and Rapamycin

Analysis of Copy Number Abnormalities of 86 Acute Lymphoblastic Leukemia Cell Lines Based on the Genetic Subtypes

Clinical Significance of LNK (SH2B3) Expression in Pediatric B Cell Precursor Acute Lymphoblastic Leukemia

MLL-AF9 Positive Acute Myeloid Leukemia Cells Are Sensitive To All-Trans Retinoic Acid

Prognostic Significance Of CRLF2 Over-Expression In Pediatric Acute Lymphoblastic Leukemia

LSD1 Inhibitor Activates Retinoic Acid Pathway in MLL Fusion Positive Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only